Home/Filings/4/0001415889-24-001062
4//SEC Filing

Kovacs Shane William Charles 4

Accession 0001415889-24-001062

CIK 0001750284other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 7:30 AM ET

Size

7.0 KB

Accession

0001415889-24-001062

Insider Transaction Report

Form 4
Period: 2024-01-12
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-12$7.02/sh+50,000$351,000484,987 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-01-1250,000187,000 total
    Exercise: $7.02Exp: 2032-01-31Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001579397

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 7:30 AM ET
Size
7.0 KB